Health

– The World Health Organization has called for stronger epidemiological surveillance after new Ebola clusters were detected in remote areas of the Democratic Republic of the Congo. The agency warned that security and logistical challenges are limiting access to some

Read More

– St. George’s University has called for risk-based breast cancer screening across Africa after a study found that 21.9% of women diagnosed with the disease in five sub-Saharan African countries were under the age of 40. The university urged healthcare

– The World Health Organization has launched a five-year strategy to strengthen global outbreak detection. The plan aims for every country to detect and understand emerging health threats within 24 hours by 2030. WHO unveiled the strategy during the World

TOKYO, Oct. 7, 2025: A large-scale Japanese study has found that individuals with higher dietary intake of riboflavin, also known as vitamin B2, had a significantly lower risk of developing disabling dementia over a 15-year period. The findings, published in the peer-reviewed European

SAN FRANCISCO, October 7, 2025: A new study led by researchers from Baylor College of Medicine, the Jan and Dan Duncan Neurological Research Institute at Texas Children’s Hospital, and Stanford University School of Medicine has identified how a molecule produced during exercise can

A new study has identified a potential link between the artificial sweetener sucralose and reduced effectiveness of cancer immunotherapy treatments in patients with melanoma and non-small cell lung cancer. The research, conducted by the University of Pittsburgh in collaboration with

The U.S. Food and Drug Administration (FDA) is calling for tighter federal control over 7-hydroxymitragynine (7-OH), a potent psychoactive compound derived from the kratom plant, citing its high potential for abuse and opioid-like effects. The agency has formally recommended classifying

The European Medicines Agency (EMA) has issued a positive recommendation for the authorization of lenacapavir, a twice-yearly injectable medication for HIV prevention. Marketed in Europe under the name Yeytuo by Gilead Sciences, the drug is now positioned for formal approval by